Senate Bill Looks to Federally Regulate Drug Compounding Manufacturers

This week the Senate Health, Education, Labor and Pensions Committee passes the Pharmaceutical Compounding Quality and Accountability Act, which differentiates between traditional compounding pharmacies and compounding manufacturers, according to the American Society of Anesthesiologists.

Advertisement

Compounding manufacturers are defined as companies that repackage preservative-free sterile products or make sterile products without a prescription to sell them across state lines.

If passed, the bill would submit these manufacturers to federal rules, rather than the state regulations of traditional pharmacies. ASA is monitoring the safety concerns associated with this bill, including the production of drugs in short supply.

More Articles on Anesthesia:
Best Practices: Documentation and Reporting for Post-Operative Pain Management Procedures in Anesthesia
Facilities Should Renew Efforts to Have Disaster Procedures in Place
WPAH Appoints Dr. Ahmed Badr to Anesthesiology Chair

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Anesthesia

  • The Morgantown-based West Virginia University School of Nursing is increasing its Doctor of Nursing Practice Nurse Anesthetist program from 15…

Advertisement

Comments are closed.